Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

26 trials with published results (22%)

Research Maturity

72 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

5 terminated out of 117 trials

Success Rate

93.5%

+7.0% vs benchmark

Late-Stage Pipeline

16%

19 trials in Phase 3/4

Results Transparency

36%

26 of 72 completed with results

Key Signals

26 with results94% success

Data Visualizations

Phase Distribution

85Total
Not Applicable (33)
Early P 1 (5)
P 1 (6)
P 2 (22)
P 3 (9)
P 4 (10)

Trial Status

Completed72
Recruiting18
Unknown12
Active Not Recruiting6
Terminated5
Withdrawn3

Trial Success Rate

93.5%

Benchmark: 86.5%

Based on 72 completed trials

Clinical Trials (117)

Showing 20 of 20 trials
NCT01631617Phase 2Recruiting

Effects of Treatments on Atopic Dermatitis

NCT05649098Early Phase 1RecruitingPrimary

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

NCT06092866Not ApplicableCompleted

Digital Versus Telephone Symptom Assessment and Triage in Primary Care

NCT05723198Phase 3Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

NCT02682511Phase 2Active Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT07412691Phase 1RecruitingPrimary

A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases

NCT06237036CompletedPrimary

Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion

NCT06387654Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

NCT06563323Phase 2Recruiting

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

NCT01865032CompletedPrimary

Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis

NCT07359430RecruitingPrimary

Deep Phenotyping of CIndU

NCT06228014CompletedPrimary

Pilot Study: AI Algorithm for Dermatology Referral Optimization

NCT07341906Enrolling By InvitationPrimary

Diagnosis Evaluation Made by Artificial Inteligence in Response to a Request Made by General Praticioner on OMNIDOC to the Dermatologist of the CHU of Nice. A Comparison of This Response by the One Made by the Dermatologist.

NCT06917690Phase 3Recruiting

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

NCT04818138Not ApplicableTerminated

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

NCT05759780Not ApplicableRecruiting

OCT Vibrography for Biomechanical Properties of Tissues

NCT05185258Phase 4Active Not Recruiting

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

NCT07158879RecruitingPrimary

Skin Reactions Related to Thoracic Implantable Chamber Dressings

NCT06353087Recruiting

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

NCT03563066Phase 2Completed

Effect of Benralizumab in Atopic Dermatitis

Scroll to load more

Research Network

Activity Timeline